How Does Canada Regulate Medications?
What should you pay special attention when ordering the drugs?
The world community has accumulated a large number of open and sensitive issues related to trafficking in falsified and substandard medicines, as they not only are a huge health risk, but also threatens human life and undermines the credibility of the health system.
Over the past decade the environment in which the strategy of fight against counterfeiting have changed substantially. With the development of international trade, the expansion of the Internet and its commercial use, the presence of “free zones” in international trade and increasingly easy access to modern printing and production resources has become more difficult to fight effectively against manufacturers and distributors of counterfeit medicines. The problem of counterfeiting of medicines affects all countries without exception, and the methods of fraud become increasingly sophisticated.
In the framework of intergovernmental organizations: Council of Europe (COE), European Union (EU) and the Commonwealth of Independent States (CIS) countries and intergovernmental organizations of a universal character such as the United Nations (UN), world health organization (who) developed a number of programs aimed at combating drug counterfeiting.
According to the who and other international organizations, counterfeit drugs are found in most countries in the world. There is no country in which the number of messages decreased. In most countries their growth.
If you leave a prescription, then first of all find out the patient’s diagnosis and the presence of appropriate indications to the user.
As you know, in language the concept of “synonymous” does not always imply their absolute semantic identity. The same pattern is observed in the case of medicines-synonyms: identical with the existing substance, they often differ substantially on a number of properties, even if available in the same dosage forms. Canada has strict regulations about medicine. For example, the doctor prescribed the patient to take Diclofenac 50 mg 3 times a day. Choosing, say, between nominally synonymous tableted drugs Rapten-rapid and Diclofenac-sodium the pharmacist in this example must necessarily make a number of clarifications concerning the clinical picture of the disease, since the first contains the active substance in the form of potassium salt, the second – in the form of sodium, and, as we know, the ions K+ and Na+ are biochemical antagonists. Synonymous drugs can vary on a wide range of biopharmaceutical parameters such as the field of absorption, bioavailability, etc., and hence the degree of the final action on an organism of the patient.
Finally, we must not lose sight of the marketing techniques of manufacturers that are trying to find for your “child” untapped market niche, have positioned the medication so that his testimony is possibly the minimum coincided with the testimony of competitive drugs-synonyms, which have already established in the market.
